- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0005 - Volume
1,100 - Avg. Volume
0 - Market Cap (intraday)
5.431M - Beta (5Y Monthly) -410.84
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Recent News: NTII
View MorePerformance Overview: NTII
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NTII
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NTII
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
73.72%
Return on Assets (ttm)
--
Return on Equity (ttm)
99.72%
Revenue (ttm)
25.32M
Net Income Avi to Common (ttm)
18.67M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
26.49M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--